Cortland Associates’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.1M | Sell |
116,495
-3,992
| -3% | -$1.13M | 4.64% | 7 |
|
|
2026
Q1 | $32.1M | Sell |
120,487
-3,941
| -3% | -$1.09M | 4.61% | 10 |
|
|
2025
Q4 | $34.2M | Sell |
124,428
-2,063
| -2% | -$578K | 4.32% | 10 |
|
|
2025
Q3 | $36.5M | Sell |
126,491
-86
| -0.1% | -$25.4K | 4.31% | 10 |
|
|
2025
Q2 | $41.8M | Sell |
126,577
-4
| -0% | -$1.29K | 4.88% | 8 |
|
|
2025
Q1 | $41.6M | Sell |
126,581
-363
| -0.3% | -$109K | 5% | 8 |
|
|
2024
Q4 | $35.1M | Sell |
126,944
-48,495
| -28% | -$15.5M | 3.99% | 12 |
|
|
2024
Q3 | $60.8M | Sell |
175,439
-2,084
| -1% | -$717K | 7.38% | 3 |
|
|
2024
Q2 | $58.7M | Sell |
177,523
-1,185
| -0.7% | -$409K | 7.42% | 3 |
|
|
2024
Q1 | $64.9M | Sell |
178,708
-1,960
| -1% | -$645K | 8.4% | 2 |
|
|
2023
Q4 | $54.1M | Sell |
180,668
-609
| -0.3% | -$178K | 7.92% | 4 |
|
|
2023
Q3 | $51.9M | Buy |
181,277
+38,346
| +27% | +$10.9M | 8.13% | 2 |
|
|
2023
Q2 | $40.1M | Sell |
142,931
-6,189
| -4% | -$1.61M | 6.46% | 5 |
|
|
2023
Q1 | $38.1M | Sell |
149,120
-39,542
| -21% | -$11.5M | 6.07% | 7 |
|
|
2022
Q4 | $62.5M | Sell |
188,662
-1,686
| -0.9% | -$533K | 10.36% | 2 |
|
|
2022
Q3 | $52.8M | Sell |
190,348
-51,308
| -21% | -$14.4M | 9.4% | 2 |
|
|
2022
Q2 | $63.7M | Sell |
241,656
-31,090
| -11% | -$8.01M | 10.53% | 1 |
|
|
2022
Q1 | $65.4M | Sell |
272,746
-10,956
| -4% | -$2.56M | 8.33% | 3 |
|
|
2021
Q4 | $65.1M | Buy |
283,702
+6,239
| +2% | +$1.33M | 6.77% | 4 |
|
|
2021
Q3 | $55.5M | Buy |
277,463
+66,535
| +32% | +$14.5M | 6.11% | 7 |
|
|
2021
Q2 | $50M | Sell |
210,928
-609
| -0.3% | -$152K | 5.23% | 7 |
|
|
2021
Q1 | $51.1M | Sell |
211,537
-4,286
| -2% | -$955K | 5.83% | 6 |
|
|
2020
Q4 | $44.9M | Sell |
215,823
-2,378
| -1% | -$466K | 5.41% | 7 |
|
|
2020
Q3 | $37M | Sell |
218,201
-98,711
| -31% | -$17.4M | 4.96% | 9 |
|
|
2020
Q2 | $59.5M | Buy |
316,912
+686
| +0.2% | +$130K | 8.77% | 3 |
|
|
2020
Q1 | $56M | Buy |
316,226
+8,159
| +3% | +$1.58M | 10.51% | 3 |
|
|
2019
Q4 | $63M | Buy |
308,067
+23,569
| +8% | +$4.32M | 8.91% | 3 |
|
|
2019
Q3 | $43.2M | Buy |
284,498
+36,585
| +15% | +$5.95M | 7.64% | 5 |
|
|
2019
Q2 | $39.1M | Sell |
247,913
-3,474
| -1% | -$544K | 6.18% | 7 |
|
|
2019
Q1 | $40.4M | Buy |
251,387
+9,116
| +4% | +$1.66M | 6.53% | 7 |
|
|
2018
Q4 | $46M | Buy |
+242,271
| New | +$50.5M | 8.35% | 3 |
|
Other funds holding CI
Cortland Associates's CI Position: Q2 2026 in Review
Cortland Associates reduced its Cigna (CI) stake by 3.3% in Q2 2026, selling an estimated $1.13M and leaving 116,495 shares worth $32.1M. The position accounts for 4.64% of the portfolio, ranked #7.
Cortland Associates first reported a position in CI in Q4 2018 and has held it in 31 quarters since. The position peaked at $65.4M in Q1 2022. 1,702 funds tracked by Wall St. Rank hold CI as of Q2 2026.
- Cortland Associates held 116,495 shares of Cigna worth $32.1M as of Q2 2026.
- Cortland Associates sold 3,992 Cigna shares in Q2 2026, an estimated $1.13M.
- Cigna made up 4.64% of Cortland Associates's portfolio in Q2 2026, its #7 holding.
- Cortland Associates first reported a position in Cigna in Q4 2018 and has held it in 31 quarters since.
- Cortland Associates's Cigna position peaked at $65.4M in Q1 2022.
- 1,702 funds tracked by Wall St. Rank held Cigna as of Q2 2026.
Based on Cortland Associates's 13F filing for Q2 2026, filed 28 Jul 2026.